Impact of weight gain with dolutegravir on antiretroviral adherence and viral suppression in four African countries.

Matthew L RomoAllahna L EsberJohn OwuothJonah MaswaiValentine Sing'oeiMichael IroezinduEmmanuel BahemanaHannah KibuukaJ Sean CavanaughNeha ShahJulie A AkeTrevor A Crowellnull null

Published in: HIV medicine (2023)

Although a substantial proportion of participants experienced weight gain after switching to TLD, we did not identify a significant impact on adherence or virological outcomes.

Keyphrases

weight gain
hiv infected patients
antiretroviral therapy
hiv infected
body mass index
birth weight
human immunodeficiency virus
hiv aids
glycemic control
hiv positive
sars cov
weight loss
insulin resistance
physical activity
men who have sex with men